Life-Sciences-Scandinavia.com
The Nordic Life Sciences Web Portal

This is a free web portal for the life sciences in the Nordic countries Denmark, Finland, Iceland, Norway and Sweden... » read more

Teitur Trophics Raises €28m Series A Financing (2023-03-14)
> Financing co-led by Sunstone Life Science Ventures and Sound Bioventures with participation from Industrifonden, Innovestor’s Life Science Fund and P53 Invest > Discovery of a novel mechanism with the potential to prevent the death of neurons in neurodegenerat...
Oncopeptides CSO Arrested by Economic Crime Authority (2023-03-08)
Oncopeptides AB (publ), has been informed by the Swedish Economic Crime Authority that the CSO Jakob Lindberg has been arrested for a suspected violation of the Market Abuse Act (Sw. lag om straff för marknadsmissbruk på värdepappersmarknaden). The Company does ...
Oculis Lists at Nasdaq via SPAC Merger with $117m in Cash (2023-03-03)
> Closing of business combination with European Biotech Acquisition Corp. creates Nasdaq-listed ophthalmology company, under the ticker “OCS”, with advanced clinical-stage pipeline of multiple product candidates in key areas of medical needs such as retina, dry eye...
New Bico Platform Integrates ABB Robotics Technology (2023-02-27)
BICO Group’s business area Bioautomation is expanding its manufacturing product offering by introducing The Nucleus™ Automation Ecosystem, a fully integrated platform bringing a new level of modularity, flexibility and scalability to the manufacturing market. De...
Resalis Therapeutics Closes €10m Seed Round Led by Claris (2023-02-22)
Resalis Therapeutics today announced its completion of the seed financing round of €10 million to establish a non-coding RNA (ncRNA)-based therapeutic approach for the treatment of metabolic diseases. The funding will support the finalization of IND-enabling studie...
Hemab Closes $135m Series B Led by Access Biotechnology (2023-02-21)
Funding enables completion of ongoing Phase 1/2 study of bispecific antibody HMB-001 in Glanzmann Thrombasthenia, initiation of pivotal studies, start and conclusion of Phase 1/2 study of HMB-VWF in von Willebrand Disease, as well as future pipeline evolution. ...
Targovax: up to NOK300m Convertible Bond Facility from Atlas (2023-02-16)
> The financing will support initiation of the ONCOS-102 melanoma phase 2 and TG01 mutant RAS clinical trials and in vivo PoC studies for the ground-breaking circRNA program > The convertible bond facility with London-based Atlas Capital Markets provides a secur...
Biotage Acquires Astrea Bioseparations for $190m in Shares (2023-02-15)
Strong strategic fit extending chromatography franchise into the attractive bioprocessing market serving biologics and advanced therapeutic customers Biotage AB (publ) (“Biotage”) has entered into an agreement to acquire Astrea Bioseparations (“Astrea”), a hig...
APK AG Announces €130m Investment Round (2023-02-08)
Today, LyondellBasell, a global leader in the chemical industry and KIRKBI A/S, the family-owned holding and investment company of the LEGO® brand, announce they have signed an agreement to make an investment in APK, which specializes in a unique solvent-based recy...
Novalis Biotech Adds €0.5m to Seed Round of Rarity Bio (2023-02-06)
To further accelerate growth, Rarity Bioscience announces today a new strategic investment from Belgium based Novalis Biotech. The investment is facilitated as an oversubscription of the recent round closed in November 2022. Apart from previous owner, that round al...

Life-Sciences-Scandinavia.com is your doorway to the Nordic life sciences!

[LSS] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations

in the Scandinavian countries Denmark, Finland, Iceland, Norway and Sweden.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSS] is 100% Made in Germany!

» Start here with the latest News!

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)